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Abstract
Objective: This study was conducted to assess the reliability and precision of an endoscopic grading scale to
identify renal papillary abnormalities across a spectrum of equipment, locations, graders, and patients.
Materials and Methods: Intra- and interobserver reliability of the papillary grading system was assessed using
weighted kappa scoring among 4 graders reviewing a single renal papilla from 50 separate patients on
2 occasions. Grading was then applied to a cohort of patients undergoing endoscopic stone removal procedures at
two centers. Patient factors were compared with papillary scores on the level of the papilla, kidney, and patient.
Results: Graders achieved substantial (kappa >0.6) intra- and inter-rater reliability in scored domains of ductal
plugging, surface pitting, and loss of contour. Agreement for Randall’s Plaque (RP) was moderate. Papillary scoring
was then performed for 76 patients (89 kidneys, 533 papillae). A significant association was discovered between
pitting and RP that held both within and across institutions. A general linear model was then created to further assess
this association and it was found that RP score was a highly significant independent correlate of pitting score (F= 7.1;
p< 0.001). Mean pitting scores increased smoothly and progressively with increasing RP scores. Sums of the scored
domains were then calculated as a reflection of gross papillary abnormality. When analyzed in this way, a history of
stone recurrence and shockwave lithotripsy were strongly predictive of higher sums.
Conclusions: Renal papillary pathology can be reliably assessed between different providers using a newly
described endoscopic grading scale. Application of this scale to stone-forming patients suggests that the degree
of RP appreciated in the papilla is strongly associated with the presence of pitting. It also suggests that patients
with a history of recurrent stones and lithotripsy have greater burdens of gross papillary disease.
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Introduction
The renal papilla is critically important to stone path-ogenesis and is the origin of many, if not most, calcium-
based stones.1 It is known to have variable appearances based
upon different pathophysiologies and systemic stone-forming
diseases.2–5 The introduction and widespread utilization of
high-definition digital ureteroscopes have allowed urologists
an unparalleled ability to visualize the renal papilla at the
time of endoscopic stone surgery.6 Nonetheless, the signifi-
cance of variable papillary appearance remains understudied
and poorly understood.
Recently, two endoscopic papillary grading scales have been
described with the intention of standardizing the description of
papillary abnormalities.7,8 The goal is to provide a reliable
classification system that could ultimately be used to gain
greater appreciation into how stones form as well as link pap-
illary morphology to meaningful clinical endpoints. However,
these systems have yet to be applied widely and to date only
minimal single institution data have been provided. Further-
more, the mechanisms by which the abnormal papillary features
occur and how they relate to each other remain unclear. We
sought to assess both the reliability and clinical relevance of
papillary scoring by formally analyzing consistency of scoring
between urologists at two medical centers and then applying it
to patients undergoing endoscopic stone surgery at each site.
Materials and Methods
Patients at two medical centers had endoscopic mapping
and recording of their renal papillary anatomy at the time of
surgery. The study was approved by the local Institutional
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Review Board at each center (IRB 14-1111 and IRB
1010002261). Clinical characteristics and metabolic data,
when available, were collected to correlate with endoscopic
findings. Stones removed from patients were analyzed using
either Micro CT or photomicroscopy and infrared spectros-
copy (Beck Labs, Indianapolis, IN). Majority stone type was
defined as 50% or more of total stone composition: calcium
oxalate (CaOx), calcium phosphate (CaP), or uric acid (UA).
Brushite stones were considered CaP for the purposes of the
analysis. No cystine or struvite stones were included. Patient
characteristics were compared using Fisher’s exact and two-
sample t-tests. All statistics were performed using Stata 13
(Statacorp, College Station, TX) and Systat 13.1 (San Jose,
CA) with p < 0.05 considered significant.
We have recently proposed a papillary endoscopic grading
system that has been described in detail.7 Briefly, the grading
scale measures papillary appearance in the domains of ductal
plugging, surface pitting, loss of contour, and Randall’s
Plaque (RP). We have modified the scale to allow for sta-
tistical testing between all domains; as such, RP is now as-
signed a numeric value of 0, 1, or 2 in line with the other
domains (Table 1).
Validation
Four urologists at two centers met for 90 minutes and re-
viewed example cases to ensure similar comprehension of the
grading system. One senior level and one junior level urologist
graded at each center. A validation study was designed to assess
intra- and interobserver reliability between graders. Graders
independently reviewed videos of a single renal papilla from
50 patients on 2 occasions. Each video lasted between 15 and
30 seconds. The validation cohort included videos made with
both a Flex-Xc scope (KARL STORZ Endoscopy-America,
Inc.) and ACMI DUR-D digital scope (Olympus Surgical
Technologies America) at center 1 and center 2, respectively.
For this validity cohort, weighted kappa scores were cal-
culated to assess intra- and interobserver reliability.9 Inter-
pretations of kappa scores are as follows: <0 less than chance
agreement, 0.01 to 0.20 slight agreement, 0.21 to 0.40 fair
agreement, 0.41 to 0.60 moderate agreement, 0.61 to 0.80
substantial agreement, and 0.81 to 0.99 almost perfect agree-
ment.10 The videos used for this validity exercise were not
used for subsequent prospective analysis. Additionally, no
patient data were studied from whom these videos were taken.
Analysis of interaction of grading scale domains
We then applied papillary grading to patients at the time of
ureteroscopy. At center 1, 13 patients underwent bilateral
ureteroscopy with complete papillary mapping and 63 pa-
tients at center 2 underwent unilateral ureteroscopy. A
complete video was created using a Flex-Xc scope (KARL
STORZ Endoscopy-America, Inc.) at center 1 and an ACMI
digital scope (Olympus Surgical Technologies America) at
center 2. Short clips of the papillae were made such that each
papilla was featured. Two reviewers at each center applied
the scoring system to each video. This was done in sequence
for each patient at center 1 and in a completely randomized
order at center 2.
After papillary scoring was completed, we sought to de-
termine the associations between domains of ductal plugging,
surface pitting, loss of contour, and RP. Spearman correlation
coefficients were calculated for this purpose. Kruskal–Wallis
testing was applied to compare subgroup median scores.
Furthermore, we utilized backward-stepping general linear
modeling (GLM) in a data-driven mode with Akaike infor-
mation criterion to assess significant predictors of domain
scores. This analysis pooled scores from all four graders;
therefore, particular graders and institutions did not enter the
model. Significance of adjusted means was assessed with
Tukey’s honestly significant difference test.
Analysis of papillary disease sum
Scores of each domain were added to create a final sum to
test their ability to reflect gross papillary abnormality. By
definition, the lowest possible score is 0 and maximum possible
score is 8. Scores were calculated for each papilla. Papillae
were then averaged across kidneys as well as across patients.
We assessed clinical factors associated with higher sums.
Results
Validation
From the validation cohort of 50 videos, graders consis-
tently achieved substantial intrarater agreement across all
measured domains (kappa of 0.61–0.80) (Fig. 1). Likewise,
inter-rater reliability was substantial in domains of plugging,
pitting, and loss of contour. The amount of RP achieved
moderate agreement.
Analysis across score domains
In the prospective cohort, 76 patients were enrolled (89
kidneys, 533 papillae). Patient characteristics are described
in Table 2. Notably, all patients in center 1 were recurrent
stone formers, were more likely to have undergone shock-
wave lithotripsy (SWL), and were more likely Caucasians.
Analysis using Spearman correlations revealed that the
Table 1. Scale for Abnormal Papillary Appearance
Score 0 1 2
Plugging 0 Yellow plug deposits/
dilated ducts
£5 Yellow plug deposits/
dilated ducts
>5 Yellow plug deposits/
dilated ducts
Pitting None £25% Papillary surface
involved
‡25% Papillary surface
involved
Loss of contour None Depressed Completely flattened
Amount of Randall’s Plaque Mild Moderate Severe
Final score Sum
Adopted with permission from Borofsky et al. (2015).
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strongest interaction between domains was RP and pitting.
Moderate correlation between pitting and RP was maintained
on the level of each papilla (0.515), by patient (0.606), or
averaged by kidney (0.606) (all p< 0.05). When analyzing data
from each center separately, these relationships held. When
removing patients with enteric disease, unknown stone type, or
parathyroid disease, this relationship also persisted. An illus-
tration of severe pitting and RP can be seen in Figure 2.
Other notable associations included a negative association
of plugging and RP (-0.190) and a small positive association
of contour loss with both pitting (0.283) and RP (0.149) only
on the papillary unit level (all p< 0.05). All other relationships
were independent of one another ( p> 0.05). When analyzed by
stone type, the relationships held for calcium stones, but not for
UA stone formers. In general, center 1 detected higher overall
amounts of RP with an average score of 1.2/2 for their patients
compared with 0.4/2 for center 2 ( p< 0.001). In contrast,
center 2 noted more plugging, with an average score of 0.7/2 vs
0.3/2 across all papillae ( p< 0.001).
Given the consistent correlation seen between pitting and
RP, we explored the relationship further with parametric
analysis. In each center and within each reader, increasing RP
scores were associated with increasing pitting scores. (Fig. 3)
In a GLM with the pooled pitting score as dependent variable
and age, race, SWL, stone recurrence, stone composition,
plugging score, and RP as categorical variables, we found
FIG. 1. Reliability among 4
graders for 50 papillary videos.
Table 2. Patient Characteristics by Center
Center 1 (%) Center 2 (%)
p
N= 13
Patients
N = 63
Patients
Papillae 217 316 —
Kidney 26 63 —
Gender (male) 69.2% 52.4% 0.211
Age (median, IQR) 46 (42–52) 51 (41–63) 0.14
Race (%)
Caucasian 100 47.6 0.008
African American 0 39.7
Asian 0 3.1
Other 0 9.5
BMI (median, IQR) 30.3
(24.7–33.7)
28.9
(24.5–37.3)
0.93
Majority stone type (%)
CaOx 83.3 52.4 0.325
CaP 16.7 31.8
UA 0 15.9
Etiology (%)
Parathyroid disease 7.7 9.5 1.00
Enteric disease 0 19.1 0.133
Recurrent stone 100 54.2 0.001
History of SWL 38.5 15.9 0.075
CaOx = calcium oxalate; CaP= calcium phosphate; SWL = shock-
wave lithotripsy; UA = uric acid.
FIG. 2. Illustrative still of papilla demonstrating con-
current RP (white brackets) and pitting (area highlighted by
black arrows).
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that RP score was a highly significant independent correlate
of pitting (F = 7.1; p < 0.001). Fully adjusted for recurrence
and SWL, mean pitting scores increase smoothly and pro-
gressively with increasing RP scores (Fig. 4). The remaining
variables were not significant predictors of pitting score and
did not require adjustment (Table 3).
Analysis of score totals
Total scores, a potential reflection of gross papillary abnor-
mality, were significantly different at each site with a median of
3/8 (IQR: 2–4) at center 1 vs 1.5/8 (IQR: 0.5–2.5) at center 2
( p< 0.001). Total scores were higher for those patients with a
history of prior stones [2.5 (IQR 1.5–4) vs 1(IQR: 0.5–2);
p< 0.001]. SWL was collinear with recurrence; with that in
mind, a history of SWL was associated with increased total
scores. [3 IQR:(2–4) vs 1.5 IQR:(1–3); p< 0.001]. There were
fewer recurrent stone formers at center 2 (54% vs. 100%), but at
center 2, scores for recurrent stone formers were still consis-
tently higher [1.75 (IQR: 1–3) vs 1 (IQR:0.5–2); p= 0.01].
Discussion
We sought to investigate the reliability of a recently de-
scribed papillary grading system.7 Our findings demonstrate
that the system can be used to reliably quantify the magnitude
of papillary abnormalities. Additionally, application of this
system provides unique insight into potential mechanisms of
FIG. 3. Mean pitting scores
by plaque. (A) Grader 1
Center 2, (B) Grader 2 Center
2, (C) Grader 1 Center 1, (D)
Grader 2 Center 1. On each
graph, differences between
bars were significant on
ANOVA except for the
following: A, RP score of 2
does not differ from a score
of 1, and C, RP score of 0
and 2 did not differ from 1,
but they differ from each
other.
FIG. 4. Linear relationship between mean pitting and
plaque score fully adjusted for recurrence and SWL, trend
significant <0.001. Together, recurrence and SWL were
powerfully associated with pitting (F = 18; p < 0.001). SWL,
shockwave lithotripsy.
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stone formation as well as associations between clinical
factors and papillary pathology previously not explored on a
large scale. This methodology is particularly timely as the use
of ureteroscopy as a primary treatment of upper urinary tract
stones continues to grow at a rapid rate.11 Specifically, es-
tablishing reference standards for normal and abnormal
papillary appearance could help substratify stone formers.
We currently lack reliable tools to risk stratify stone for-
mers. The ROKS nomogram has shown promise, but is based
mainly on data related to an acute stone episode that essentially
provide a snapshot in time.12 Papillary appearance presumably
provides details related to the duration and severity of disease,
as indicated by the degree of visible pathology. Other methods
of classifying stone formers such as 24-hour urine collections,
the mainstay of metabolic evaluation, are variable based on
patient compliance and diet. Likewise, stone composition
determination by traditional techniques such as photomicro-
scopy and Fourier transform infrared spectroscopy is subject to
error.13,14 In contrast, papillary pathology may be a more
stable and reliable indicator of disease severity as it is poten-
tially static and objective if measured using a validated in-
strument. Patients observed intraoperatively to have a high
burden of papillary pathology could be considered for more
aggressive surveillance or further metabolic evaluation. The
fact that recurrence and SWL history were associated with
higher scores is an early suggestion of the utility of our scale to
risk stratify patients. At least for SWL, animal models suggest
that papillary injury induces cellular fragmentation and ne-
crosis and it would not be surprising for multiple treatments to
manifest in more detectable damage on endoscopy.15
Similarly, it is likely that certain types of stone formers have
corresponding patterns of papillary abnormalities. For example,
the relationship between pitting and RP was exclusive to cal-
cium stone formers, but did not hold for UA stone formers,
indicating separate mechanisms of stone formation. This mir-
rors the current hypothesis that UA precipitates in solution ra-
ther than being affixed to the papillary surface.16 As the concept
of papillary grading continues to evolve, it is quite possible that
endoscopic papillary phenotypes might have a supplementary
role to standard techniques of classifying stone formers in
guiding more precise preventative strategies and treatments.
Further recognition of papillary pathology could also set the
stage for new theories of stone formation. Our finding that
pitting is associated with higher degrees of RP is evidence for
this concept as such observations would be impossible without
a descriptive terminology. For example, how are pits formed,
and what is their relationship to RP? One possibility is that pits
are formed when RP is pulled away by passage or removal of a
stone. Does urothelium regrow over the exposed surface? Is an
exposed surface equally susceptible to RP formation? Is the
pathophysiology of stone formation expedited or slowed as a
result of the erosion? All of these potentially important ques-
tions can only be addressed if we provide the language to make
such characterizations possible.
Our work is the largest formal assessment of papillary pa-
thology to date. Moreover, the study of relationships between
features of papillary pathology measured in each domain is
novel. Many of these features have been well described by Evan
et al., but relationships between factors (i.e., plugging and RP)
have only been studied on a smaller scale among highly selected
patient populations.2–5 It has been previously noted that non-
stone formers have no visual papillary abnormalities.1,8 Ulti-
mately, we found that pitting and RP are positively correlated,
whereas plugging is negatively associated with RP. This lends
support to the concept that stones may form through two inde-
pendent (or divergent) mechanisms. Patients with CaP stones
have previously been observed on biopsy to have collecting
ducts filled with crystal deposits or plugging.4 In contrast, pa-
tients with idiopathic CaOx stones have stone overgrowth on
RP.17 This has yet to be fully validated, but efforts such as these
will be necessary to gain greater insight into whether this will
hold true in a general population of stone formers.
Limitations
The interobserver agreement between variables in the
grading scale was not perfect. Given that static epidemiologic
data extracted from patient charts often only attain moderate
agreement among graders, we believe our preliminary reli-
ability to be promising.18,19 Furthermore, our findings reflect
the initial experience using this scale. Such efforts at creating
and applying grading scales are likely to improve with expe-
rience; for example, precision and reliability of the Gleason
scoring system, used routinely by pathologists to characterize
the aggressive potential of prostate cancer, have been shown to
improve over time with training and exposure.20 Kappa for a
given reading of Gleason scores by trained pathologists was
0.67 in a recent study.21 This demonstrates that a scoring
system need only be able to demonstrate substantial agreement
to be clinically relevant. There were significant differences
between the degree of pathology seen at both institutions, with
patients from center 1 having higher degrees of RP and center
2 having higher degrees of plugging. We suspect that this may
be due to different patient populations as center 1 specifically
recruited patients undergoing bilateral procedures and thus
more likely to have a greater degree of stone burden and more
aggressive disease. However, this can also be seen as a strength
given the fact that the relationships between pitting and RP
were maintained across each center regardless of baseline
disease. Finally, we acknowledge that this grading scale re-
quires further study among larger numbers of patients and
validation among the wider urologic community. However,
initial efforts such as the one described will be necessary in
appropriately refining the scale to ensure it is correctly cap-
turing the intended information and being interpreted with the
greatest degree of accuracy.
Table 3. Factors Associated with Pitting Corrected
for History of Recurrence and SWL
Variablea F- ratio p
Degree of RP 24.0 <0.01
History of SWL 20.4 <0.01
Interaction of history of
recurrence and SWL
18.0 <0.01
Interaction of history of
recurrence and degree of RP
3.93 <0.01
Interaction of history of
SWL and degree of RP
3.32 0.01
aStepwise selection eliminated contour score, stone type, plug-
ging score, recurrence, and their interaction variables due to F < 1.0
and p > 0.2.
RP =Randall’s Plaque.
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Conclusion
We provide evidence of the reliability and validity of a
grading system for renal papillary damage. We also note that
a relationship between RP and pitting holds despite hetero-
geneity in patients, graders, and equipment. Pitting, identified
on endoscopy, appears to be independent of plugging in any
given papillae, suggesting that each of these are unique
manifestations of papillary pathology and likely have entirely
separate associations with stone pathogenesis. Total scores, a
potential marker of overall papillary health, are correlated
with recurrence and SWL, suggesting that as the degree of
stone disease gets worse, abnormalities of the papillae be-
come more common. This grading system may have clinical
utility as a tool for research as well as intraoperative risk
stratification. As we begin to understand the implication of
papillary abnormalities, we are optimistic that it may be used
as a surrogate mechanism to tailor specific treatment strate-
gies to afflicted patients.
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